TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value NIS 0.10 per share
Symbol
TEVA on NYSE
Shares outstanding
1,147,663,152
Price per share
$32.79
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
539,662,467
Total reported value
$16,838,775,277
% of total 13F portfolios
0.02%
Share change
+64,195,379
Value change
+$2,113,999,362
Number of holders
481
Price from insider filings
$32.79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MENORA MIVTACHIM HOLDINGS LTD. 5% $961,943,099 57,395,173 Menora Mivtachim Holdings Ltd 16 Jul 2025
Phoenix Financial Ltd. 5% $961,741,722 57,383,158 Phoenix Financial Ltd. 14 Jul 2025

As of 31 Dec 2025, 481 institutional investors reported holding 539,662,467 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA). This represents 47% of the company’s total 1,147,663,152 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) together control 39% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.1% 58,302,688 +0.87% 0.03% $1,819,626,890
Harel Insurance Investments & Financial Services Ltd. 3.9% 44,951,773 +19% 12% $1,402,945,000
Phoenix Financial Ltd. 3.6% 41,087,131 -0.5% 14% $1,282,329,359
MENORA MIVTACHIM HOLDINGS LTD. 3.4% 39,316,183 +1% 5.8% $1,227,058,071
Clal Insurance Enterprises Holdings Ltd 3.3% 37,404,106 +19% 7.6% $1,171,378,000
Migdal Insurance & Financial Holdings Ltd. 3.3% 37,402,212 +15% 10% $1,167,323,000
NORGES BANK 3.1% 35,182,949 0.12% $1,098,059,838
Lingotto Investment Management LLP 2.5% 28,422,768 -0.58% 16% $887,074,589
Rubric Capital Management LP 1.9% 21,355,510 -13% 8% $666,505,467
STATE STREET CORP 1.5% 17,348,809 +1.2% 0.02% $541,456,329
WCM INVESTMENT MANAGEMENT, LLC 1.2% 14,007,078 +5493% 0.9% $438,981,825
GEODE CAPITAL MANAGEMENT, LLC 0.9% 10,326,504 +3.4% 0.02% $320,294,514
MORGAN STANLEY 0.74% 8,444,801 +30% 0.02% $263,562,311
SCHRODER INVESTMENT MANAGEMENT GROUP 0.65% 7,426,885 +261% 0.18% $231,793,081
GOLDMAN SACHS GROUP INC 0.51% 5,878,067 +16% 0.03% $183,454,485
SOUND SHORE MANAGEMENT INC /CT/ 0.38% 4,309,906 -24% 4.3% $134,512,166
BESSEMER GROUP INC 0.37% 4,280,425 +908695% 0.21% $133,592,000
UBS Group AG 0.37% 4,277,986 -24% 0.03% $133,515,930
AustralianSuper Pty Ltd 0.33% 3,841,151 -23% 0.56% $119,882,323
TODD ASSET MANAGEMENT LLC 0.33% 3,777,137 -6.4% 2.3% $117,884,625
1832 Asset Management L.P. 0.32% 3,718,454 0.15% $116,052,949
Legal & General Group Plc 0.31% 3,608,387 +6.8% 0.02% $112,617,759
Alyeska Investment Group, L.P. 0.31% 3,535,962 -41% 0.31% $110,357,374
National Pension Service 0.31% 3,500,558 +69% 0.08% $109,252,415
LORD, ABBETT & CO. LLC 0.3% 3,449,607 -0.76% 0.33% $107,662,000

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 539,662,467 $16,838,775,277 +$2,113,999,362 $31.21 481
2025 Q3 657,128,547 $13,260,788,032 -$1,074,131,323 $20.20 542
2025 Q2 712,590,449 $11,941,932,547 +$36,824,124 $16.76 533
2025 Q1 711,693,842 $10,931,543,829 +$519,379,518 $15.37 553
2024 Q4 665,647,648 $14,670,317,479 +$818,691,314 $22.04 576
2024 Q3 620,854,841 $11,183,045,547 +$327,878,111 $18.02 537
2024 Q2 607,728,519 $9,874,096,775 +$630,049,704 $16.25 528
2024 Q1 570,414,049 $8,044,022,392 -$52,732,472 $14.11 474
2023 Q4 577,047,792 $6,069,688,726 +$223,053,462 $10.44 442
2023 Q3 554,042,366 $5,650,669,709 +$626,794,069 $10.20 427
2023 Q2 494,500,315 $3,725,733,619 -$615,772,920 $7.53 415
2023 Q1 558,872,500 $4,939,868,087 -$36,845,034 $8.85 431
2022 Q4 546,063,896 $4,978,922,006 -$17,646,117 $9.12 412
2022 Q3 560,076,320 $4,512,924,774 +$430,391,292 $8.07 395
2022 Q2 505,606,590 $3,800,507,049 -$46,832,800 $7.52 423
2022 Q1 514,571,916 $4,831,771,215 +$15,212,208 $9.39 420
2021 Q4 505,268,193 $4,044,921,275 -$275,589,149 $8.01 404
2021 Q3 527,166,334 $5,134,182,484 -$316,368,771 $9.74 408
2021 Q2 560,418,706 $5,548,640,366 -$132,495,361 $9.90 423
2021 Q1 572,281,687 $6,602,414,033 +$11,656,292 $11.54 432
2020 Q4 569,047,097 $5,481,032,100 +$43,379,354 $9.65 425
2020 Q3 567,029,372 $5,101,188,907 -$198,579,913 $9.01 421
2020 Q2 578,768,724 $7,127,077,578 +$321,923,360 $12.33 435
2020 Q1 553,974,646 $4,971,872,721 -$440,161,645 $8.98 430
2019 Q4 587,644,124 $5,758,393,262 -$3,710,163 $9.80 400
2019 Q3 593,337,830 $4,080,614,277 -$370,869,093 $6.88 381
2019 Q2 640,277,265 $5,906,782,225 -$439,059,091 $9.23 434
2019 Q1 671,102,381 $10,520,363,452 -$196,656,850 $15.68 494
2018 Q4 683,508,269 $10,543,555,889 +$642,420,742 $15.42 521
2018 Q3 637,054,434 $13,721,192,032 -$678,690,147 $21.54 544
2018 Q2 666,718,989 $16,214,840,524 -$65,167,761 $24.32 524
2018 Q1 670,950,352 $11,466,263,858 +$1,343,704,129 $17.09 496
2017 Q4 589,430,624 $11,168,843,247 +$967,805,212 $18.95 492
2017 Q3 538,274,425 $9,469,175,078 -$1,193,875,685 $17.60 518
2017 Q2 588,457,468 $19,529,211,322 +$426,728,940 $33.22 644
2017 Q1 577,358,917 $18,532,232,773 +$137,211,832 $32.09 683
2016 Q4 600,379,250 $21,762,160,758 +$663,343,961 $36.25 728
2016 Q3 568,093,200 $26,108,610,817 -$1,245,501,967 $46.01 787
2016 Q2 595,232,782 $29,899,759,479 -$270,337,135 $50.23 803
2016 Q1 599,509,350 $32,089,875,470 -$618,707,055 $53.51 827
2015 Q4 609,619,633 $40,013,406,301 +$4,897,531,260 $65.64 871
2015 Q3 528,234,068 $29,829,088,508 +$720,659,838 $56.46 812
2015 Q2 515,345,024 $30,452,110,183 -$418,903,526 $59.10 813
2015 Q1 522,197,012 $32,524,459,275 +$477,967,796 $62.30 819
2014 Q4 517,436,058 $29,747,687,457 +$759,784,446 $57.51 815
2014 Q3 499,883,869 $26,854,835,386 +$666,480,537 $53.75 764
2014 Q2 487,041,912 $25,535,694,806 +$617,581,810 $52.42 773
2014 Q1 472,293,493 $24,932,366,379 +$1,013,203,448 $52.84 765